Evidence map›Paper›PMID 35992942›Full record

SynthesisFrontiers in human neuroscience2022

Resting and TMS-EEG markers of treatment response in major depressive disorder: A systematic review.

Rebecca Strafella, Robert Chen, Tarek K Rajji, Daniel M Blumberger, Daphne Voineskos

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in human neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Rebecca StrafellaInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Robert ChenInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Tarek K RajjiInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Daniel M BlumbergerInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Daphne VoineskosInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
University of Toronto · CACentre for Addiction and Mental Health · CAKrembil Research Institute

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electroencephalography (EEG) is a non-invasive method to identify markers of treatment response in major depressive disorder (MDD). In this review, existing literature was assessed to determine how EEG markers change with different modalities of MDD treatments, and to synthesize the breadth of EEG markers used in conjunction with MDD treatments. PubMed and EMBASE were searched from 2000 to 2021 for studies reporting resting EEG (rEEG) and transcranial magnetic stimulation combined with EEG (TMS-EEG) measures in patients undergoing MDD treatments. The search yielded 966 articles, 204 underwent full-text screening, and 51 studies were included for a narrative synthesis of findings along with confidence in the evidence. In rEEG studies, non-linear quantitative algorithms such as theta cordance and theta current density show higher predictive value than traditional linear metrics. Although less abundant, TMS-EEG measures show promise for predictive markers of brain stimulation treatment response. Future focus on TMS-EEG measures may prove fruitful, given its ability to target cortical regions of interest related to MDD.

Indexed as

antidepressantbiomarkerselectroencephalography (EEG)major depressive disorder (MDD)repetitive transcranial magnetic stimulation (rTMS)TMS-EEGtranscranial magnetic stimulation (TMS)treatment

Identifiers

PMID35992942
PMCPMC9387384
OpenAlexW4289845952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.